site stats

Sutro biopharma stock

WebSTRO Stock 12 Months Forecast. $18.67. (306.75% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $18.67 with a high forecast of $26.00 and a low forecast of $8.00. The average price target represents a 306.75% change from the last price of $4.59. WebSutro Biopharma, Inc. (STRO) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. 4.7700 +0.1700 (+3.70%) At close: 04:00PM EDT. 5.0000 +0.23 (+4.82%)

Sutro Biopharma, Inc. (STRO) Stock Historical Prices & Data

Web12 apr 2024 · Sutro Biopharma. stock last closed at $4.25, down 3.19% from the previous day, and has decreased 43.86% in one year. It has underperformed other stocks in the Biotechnology industry by 0.21 percentage points. Sutro Biopharma stock is currently +27.63% from its 52-week low of $3.33, ... WebSutro Biopharma Inc (STRO) Stock Price & News - Google Finance Home STRO • NASDAQ Sutro Biopharma Inc Follow Share $4.59 After Hours: $4.59 (0.00%) 0.00 … tennessee tech apply to graduate https://balverstrading.com

Biotech Stock Sutro Collapses; Why One Analyst Believes It Will …

Web13 mar 2024 · Sutro Biopharma, Inc. is a clinical stage drug discovery, development, and manufacturing company. It is focused on deploying its integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF, to create a variety of protein therapeutics, initially for cancer. It is engaged in designing therapeutics using potent ... WebSutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on … Web6 apr 2024 · A high-level overview of Sutro Biopharma, Inc. (STRO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. trey songz about you instrumental

SUTRO BIOPHARMA, INC. : Stock Market News and Information …

Category:Sutro Biopharma, Inc. is a public biotechnology company focused …

Tags:Sutro biopharma stock

Sutro biopharma stock

Sutro Biopharma Inc. (STRO) Recovers 54.05% From Low: Are We …

Web3 apr 2024 · Most relevant news about SUTRO BIOPHARMA, INC. Truist Securities Adjusts Sutro Biopharma's Price Target to $25 From $21, Keeps Buy Rat.. Transcript : Sutro Biopharma, Inc. Presents at 41st Annual J.P. Morgan Health.. Piper Sandler Adjusts Price Target on Sutro Biopharma to $18 From $16, Maintains Overwe.. Web6 apr 2024 · View Sutro Biopharma, Inc STRO investment & stock information. Get the latest Sutro Biopharma, Inc STRO detailed stock quotes, stock data, Real-Time ECN, …

Sutro biopharma stock

Did you know?

WebStock Data; SEC Filings; Governance; Pipeline; News. News Releases; Clinical / Scientific Presentation & Publication Highlights; Events; Events Audio Replays; ... Sutro Biopharma. 111 Oyster Point Blvd South San Francisco, CA 94080 Phone: 650-881-6500 Fax: 650-553-9659. Google Map. Tweets by @sutrobio. Contact Us. Web15 giu 2024 · Sutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57M Seeking Alpha 10d Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates

WebDescription. Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical … Web30 mar 2024 · The non-operating, unrealized gain of $12.1 million for the year 2024 was due to the increase since December 31, 2024 in the estimated fair value of Sutro’s holdings of Vaxcyte common stock. Vaxcyte common stock held by Sutro will be remeasured at fair value based on the closing price of Vaxcyte’s common stock on the last trading day of ...

Web10 apr 2024 · Comparatively, Sutro Biopharma has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Insider & Institutional Ownership 99.5% of Coherus BioSciences shares are ... Web21 mar 2024 · Sutro Biopharma Quant Rating and Wall St. Analysts rating both stands with Buy (5 Very Bullish, 3 Bullish). Since the start of 2024, Sutro Biopharma shares were …

Web24 mar 2024 · Stock Price Forecast. According to 15 stock analysts, the average 12-month stock price forecast for STRO stock is $ 22.57 , which predicts an increase of 376.16%. …

Web27 mar 2024 · Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical … trey songz album 2020Web31 mar 2024 · Stay up to date on Sutro Biopharma analyst ratings. If you are interested in following small-cap stock news and performance you can start by tracking it here. trey songz about you album coverWebFind real-time STRO - Sutro Biopharma Inc stock quotes, company profile, news and forecasts from CNN Business. ... Sutro Biopharma Inc (NASDAQ:STRO) 4.38. Delayed Data. As of 4:00pm ET tennessee tech bookstore onlineWeb1 giorno fa · Sutro Biopharma, Inc. (STRO) Stock Price, Quote & News - Stock Analysis Sutro Biopharma, Inc. ( STRO) NASDAQ: STRO · IEX Real-Time Price · USD 5.13 … trey songz - about da gameWeb3 apr 2024 · JMP Securities analyst Reni Benjamin reiterated a Buy rating on Sutro Biopharma (STRO – Research Report) today and set a price target of $17.00.The company’s shares closed last Friday at $4.62 tennessee tech athletic directorWebSUTRO BIOPHARMA, INC. : Financial news and information Stock SUTRO BIOPHARMA, INC. Nasdaq: STRO Nasdaq tennessee tech baseballWeb6 apr 2024 · 7.87%. Trailing 12-Months. The Sutro Biopharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system … tennessee tech athletic facilities